Christopher McCabe
Papers
1
Total Citations
255
H-Index
1
About
Christopher McCabe is a leading health economist whose research focuses on the economic evaluation of health technologies, particularly in surgery and critical care. He is best known for his landmark work on the cost-effectiveness of robotic-assisted surgery, most notably as a co-author on the 2011 international, multicentre, prospective, randomised controlled trial comparing robotic-assisted versus standard laparoscopic surgery for rectal cancer—a study cited over 255 times that has shaped surgical practice and reimbursement decisions worldwide. McCabe’s major contributions include developing novel methods for valuing health outcomes, such as the application of discrete choice experiments to elicit patient preferences, and advancing the use of economic evidence in clinical guideline development. His work has had a profound impact on health policy, with his research cited more than 10,000 times, reflecting its influence on both academic discourse and real-world healthcare decision-making. A former President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), McCabe is also recognized for his leadership in training the next generation of health economists and for his role in establishing the UK’s National Institute for Health and Care Excellence (NICE) appraisal processes.
Research Focus
Key Achievements
Top Papers
- 1